18,731
Total Claims
$4.8M
Drug Cost
1,481
Beneficiaries
$3,243
Cost/Patient
Peer Comparison vs. 9,082 Pulmonary Disease providers
-37%
Cost per patient vs peers
$3,243 vs $5,138 avg
Brand vs Generic
100% generic
Brand: 0 claims · $0
Generic: 9,850 claims · $360K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Budesonide/Formoterol Fumarate | 2,361 | $925K |
| Nintedanib Esylate | 64 | $801K |
| Fluticasone Propion/Salmeterol | 941 | $491K |
| Fluticasone/Vilanterol | 930 | $370K |
| Fluticasone Propion/Salmeterol | 718 | $329K |
| Tiotropium Bromide | 513 | $270K |
| Tiotropium Br/Olodaterol Hcl | 477 | $229K |
| Fluticasone/Umeclidin/Vilanter | 344 | $222K |
| Fluticasone Propion/Salmeterol | 916 | $192K |
| Tiotropium Bromide | 178 | $93K |
| Budesonide/Formoterol Fumarate | 314 | $93K |
| Dupilumab | 24 | $87K |
| Dupilumab | 20 | $73K |
| Tezepelumab-Ekko | 16 | $66K |
| Albuterol Sulfate | 1,338 | $63K |
Prescribing Profile
42
Unique Drugs
Patient Profile
71
Avg Age
63%
Female
2.43
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About